Cargando…
Symptoms Relevant to Surveillance for Ovarian Cancer
To examine how frequently and confidently healthy women report symptoms during surveillance for ovarian cancer. A symptoms questionnaire was administered to 24,526 women over multiple visits accounting for 70,734 reports. A query of reported confidence was included as a confidence score (CS). Chi sq...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5373027/ https://www.ncbi.nlm.nih.gov/pubmed/28335512 http://dx.doi.org/10.3390/diagnostics7010018 |
_version_ | 1782518740738375680 |
---|---|
author | Ore, Robert M. Baldwin, Lauren Woolum, Dylan Elliott, Erika Wijers, Christiaan Chen, Chieh-Yu Miller, Rachel W. DeSimone, Christopher P. Ueland, Frederick R. Kryscio, Richard J. van Nagell, John R. Pavlik, Edward J. |
author_facet | Ore, Robert M. Baldwin, Lauren Woolum, Dylan Elliott, Erika Wijers, Christiaan Chen, Chieh-Yu Miller, Rachel W. DeSimone, Christopher P. Ueland, Frederick R. Kryscio, Richard J. van Nagell, John R. Pavlik, Edward J. |
author_sort | Ore, Robert M. |
collection | PubMed |
description | To examine how frequently and confidently healthy women report symptoms during surveillance for ovarian cancer. A symptoms questionnaire was administered to 24,526 women over multiple visits accounting for 70,734 reports. A query of reported confidence was included as a confidence score (CS). Chi square, McNemars test, ANOVA and multivariate analyses were performed. 17,623 women completed the symptoms questionnaire more than one time and >9500 women completed it more than one four times for >43,000 serially completed questionnaires. Reporting ovarian cancer symptoms was ~245 higher than ovarian cancer incidence. The positive predictive value (0.073%) for identifying ovarian cancer based on symptoms alone would predict one malignancy for 1368 cases taken to surgery due to reported symptoms. Confidence on the first questionnaire (83.3%) decreased to 74% when more than five questionnaires were completed. Age-related decreases in confidence were significant (p < 0.0001). Women reporting at least one symptom expressed more confidence (41,984/52,379 = 80.2%) than women reporting no symptoms (11,882/18,355 = 64.7%), p < 0.0001. Confidence was unrelated to history of hormone replacement therapy or abnormal ultrasound findings (p = 0.30 and 0.89). The frequency of symptoms relevant to ovarian cancer was much higher than the occurrence of ovarian cancer. Approximately 80.1% of women expressed confidence in what they reported. |
format | Online Article Text |
id | pubmed-5373027 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-53730272017-04-05 Symptoms Relevant to Surveillance for Ovarian Cancer Ore, Robert M. Baldwin, Lauren Woolum, Dylan Elliott, Erika Wijers, Christiaan Chen, Chieh-Yu Miller, Rachel W. DeSimone, Christopher P. Ueland, Frederick R. Kryscio, Richard J. van Nagell, John R. Pavlik, Edward J. Diagnostics (Basel) Article To examine how frequently and confidently healthy women report symptoms during surveillance for ovarian cancer. A symptoms questionnaire was administered to 24,526 women over multiple visits accounting for 70,734 reports. A query of reported confidence was included as a confidence score (CS). Chi square, McNemars test, ANOVA and multivariate analyses were performed. 17,623 women completed the symptoms questionnaire more than one time and >9500 women completed it more than one four times for >43,000 serially completed questionnaires. Reporting ovarian cancer symptoms was ~245 higher than ovarian cancer incidence. The positive predictive value (0.073%) for identifying ovarian cancer based on symptoms alone would predict one malignancy for 1368 cases taken to surgery due to reported symptoms. Confidence on the first questionnaire (83.3%) decreased to 74% when more than five questionnaires were completed. Age-related decreases in confidence were significant (p < 0.0001). Women reporting at least one symptom expressed more confidence (41,984/52,379 = 80.2%) than women reporting no symptoms (11,882/18,355 = 64.7%), p < 0.0001. Confidence was unrelated to history of hormone replacement therapy or abnormal ultrasound findings (p = 0.30 and 0.89). The frequency of symptoms relevant to ovarian cancer was much higher than the occurrence of ovarian cancer. Approximately 80.1% of women expressed confidence in what they reported. MDPI 2017-03-20 /pmc/articles/PMC5373027/ /pubmed/28335512 http://dx.doi.org/10.3390/diagnostics7010018 Text en © 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ore, Robert M. Baldwin, Lauren Woolum, Dylan Elliott, Erika Wijers, Christiaan Chen, Chieh-Yu Miller, Rachel W. DeSimone, Christopher P. Ueland, Frederick R. Kryscio, Richard J. van Nagell, John R. Pavlik, Edward J. Symptoms Relevant to Surveillance for Ovarian Cancer |
title | Symptoms Relevant to Surveillance for Ovarian Cancer |
title_full | Symptoms Relevant to Surveillance for Ovarian Cancer |
title_fullStr | Symptoms Relevant to Surveillance for Ovarian Cancer |
title_full_unstemmed | Symptoms Relevant to Surveillance for Ovarian Cancer |
title_short | Symptoms Relevant to Surveillance for Ovarian Cancer |
title_sort | symptoms relevant to surveillance for ovarian cancer |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5373027/ https://www.ncbi.nlm.nih.gov/pubmed/28335512 http://dx.doi.org/10.3390/diagnostics7010018 |
work_keys_str_mv | AT orerobertm symptomsrelevanttosurveillanceforovariancancer AT baldwinlauren symptomsrelevanttosurveillanceforovariancancer AT woolumdylan symptomsrelevanttosurveillanceforovariancancer AT elliotterika symptomsrelevanttosurveillanceforovariancancer AT wijerschristiaan symptomsrelevanttosurveillanceforovariancancer AT chenchiehyu symptomsrelevanttosurveillanceforovariancancer AT millerrachelw symptomsrelevanttosurveillanceforovariancancer AT desimonechristopherp symptomsrelevanttosurveillanceforovariancancer AT uelandfrederickr symptomsrelevanttosurveillanceforovariancancer AT krysciorichardj symptomsrelevanttosurveillanceforovariancancer AT vannagelljohnr symptomsrelevanttosurveillanceforovariancancer AT pavlikedwardj symptomsrelevanttosurveillanceforovariancancer |